A non-interventional naturalistic project to investigate the effect of the use of SMS text service on treatment adherence in patients treated with Seroquel® (quetiapine) - SEQUEL

Inclusion Criteria

• - The subjects should be considered eligible for this trail according to the physician:
• 1. Patients with a diagnose of schizophrenia or bipolar disorder with a recent manic episode
• 2. Patients who are being treated with quetiapine and are on an effective dose according to the Core Data Sheet; for schizophrenia between 300 and 450 mg (maximum 750 mg) and bipolar disorder between 400 and 800 mg.
• 3. Patients who consent to make the coded data available to AstraZeneca; provision of written informed consent
• 4. Considered eligible for this study and able to understand and comply with the requirements of the study according to the physician
• 5. In possession of a private mobile phone and capable of using this mobile phone to send SMS text messages